Recon: FDA authorizes Pfizer’s RSV vaccine for pregnant women; Teva to shell out $225M to resolve US price-fixing case
ReconJason Scott
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy